0001574774-19-000006.txt : 20190201 0001574774-19-000006.hdr.sgml : 20190201 20190201173510 ACCESSION NUMBER: 0001574774-19-000006 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190131 FILED AS OF DATE: 20190201 DATE AS OF CHANGE: 20190201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Getz Heather C CENTRAL INDEX KEY: 0001481485 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55039 FILM NUMBER: 19560962 MAIL ADDRESS: STREET 1: 227 WASHINGTON STREET, #300 CITY: CONSHOHOCKEN STATE: PA ZIP: 19428 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOTELEMETRY, INC. CENTRAL INDEX KEY: 0001574774 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 462568498 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 CEDAR HOLLOW ROAD CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 610-729-7000 MAIL ADDRESS: STREET 1: 1000 CEDAR HOLLOW ROAD CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: BioTelemetry, Inc. DATE OF NAME CHANGE: 20130418 4 1 wf-form4_154906049430857.xml FORM 4 X0306 4 2019-01-31 0 0001574774 BIOTELEMETRY, INC. BEAT 0001481485 Getz Heather C 1000 CEDAR HOLLOW RD. SUITE 102 MALVERN PA 19355 0 1 0 0 Executive VP & CFO Common Stock 2019-01-31 4 M 0 100 2.80 A 80661 D Common Stock 2019-01-31 4 S 0 100 70.01 D 80561 D Common Stock 2019-02-01 4 M 0 10490 2.80 A 91051 D Common Stock 2019-02-01 4 S 0 10490 70.41 D 80561 D Stock Options (Right to Buy) 2.8 2019-01-31 4 M 0 100 0 D 2022-02-21 Common Stock 100.0 10490 D Stock Options (Right to Buy) 2.8 2019-02-01 4 M 0 10490 0 D 2022-02-21 Common Stock 10490.0 0 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2018. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $70.00 to $72.12, inclusive. The reporting person undertakes to provide to BioTelemetry, Inc., any security holder of BioTelemetry, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. The stock options vested in four equal annual installments, which began on December 31, 2012. The options were fully exercisable as of December 31, 2015. /s/ Peter F. Ferola, Attorney-in-Fact 2019-02-01